825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA
Vaxcyte, Inc. Issues $575 Million Convertible Senior Notes Due 2032
Investor Presentation
Reports Second Quarter 2026 Financial Results and Provides Business Update
Director Retirement - Heath Lukatch Steps Down from Vaxcyte Board
Director Retirement - Jacks Lee Steps Down from Vaxcyte Board
Vaxcyte, Inc. Annual Meeting Results - Directors Elected
Reports First Quarter 2026 Financial Results and Provides Business Update
Q2
Q1
FY 2024
Q3
FY 2023
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
Definitive Proxy Statement
Additional Proxy Materials
PRE 14A
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Free Writing Prospectus
Prospectus filed pursuant to Rule 305(b)(2)
Submission Upload